{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Genmab A/S", "item": "https://www.patentleaderboard.com/company/genmab-as"}, {"@type": "ListItem", "position": 3, "name": "Patrick ENGELBERTS", "item": "https://www.patentleaderboard.com/inventor/fl:pa_ln:engelberts-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
PE

Patrick ENGELBERTS — 7 Patents

GAGenmab A/S: 7 patents #24 of 142Top 20%
Utrecht, NL: #111 of 1,053 inventorsTop 15%
Overall (All Time): #680,018 of 4,157,543Top 20%
7 Patents All Time
Patrick ENGELBERTS has been granted 7 US patents while listed as an inventor at Genmab A/S. The first was granted in 2020 and the most recent in April 2024. Patrick ENGELBERTS ranks #680,018 of 4,157,543 US inventors in our database (top 16.4%). Patent records list Patrick ENGELBERTS in Utrecht, NL.

Patents per Year

Patents granted per year, 2020 to 2024Bar chart with a peak of 2 patents in 2021.peak 22020: 1 patents20202021: 2 patents20212022: 2 patents20222023: 1 patents20232024: 1 patents2024

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11970544 Antibodies David Satijn, Esther BREIJ, Bart DE GOEIJ, Kristel Kemper, Edward Norbert Van Den Brink +4 more 2024-04-30 $9,571,000
11814437 Antibodies binding to CD30 and CD3 David Satijn, Kristel Kemper, Esther BREIJ, Simone OOSTINDIE, Farshid ALEMDEHY 2023-11-14 $8,609,000
11359015 Humanized or chimeric CD3 antibodies Rik RADEMAKER, Isil Altintas, Janine Schuurman, Paul Parren 2022-06-14
11261254 Antibodies Louise A. Koopman, Dennis VERZIJL, Edward Norbert Van Den Brink, Rik RADEMAKER, Sieto BOSGRA +3 more 2022-03-01
11130819 Antibodies David Satijn, Esther BREIJ, Bart DE GOEIJ, Kristel Kemper, Edward Norbert Van Den Brink +4 more 2021-09-28
11008399 Antibodies David Satijn, Esther BREIJ, Bart DE GOEIJ, Kristel Kemper, Edward Norbert Van Den Brink +4 more 2021-05-18
10544220 Bispecific antibodies against CD3 and CD20 Esther BREIJ, Rik RADEMAKER, Isil Altintas, David Satijn, Sandra VERPLOEGEN +4 more 2020-01-28 $4,317,000